药物研发-话题@MedSci

#药物研发#

120篇内容 | 3955人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301421, encodeId=913a1301421a8, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Science：药物研发新革命, objectType=article, longId=50461, objectId=e6f450461fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6f450461fd, replyNumber=0, likeNumber=70, createdTime=2015-05-10, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6f450461fd, moduleTitle=Science：药物研发新革命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6f450461fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301420, encodeId=104113014202a, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Google如何用机器学习帮助药物研发？, objectType=article, longId=47786, objectId=b8ef4e786bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8ef4e786bb, replyNumber=0, likeNumber=70, createdTime=2015-03-07, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8ef4e786bb, moduleTitle=Google如何用机器学习帮助药物研发？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8ef4e786bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301419, encodeId=87241301419db, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=阿斯利康宣布成立抗感染药物研发新公司, objectType=article, longId=47598, objectId=c8eb4e59819, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8eb4e59819, replyNumber=0, likeNumber=55, createdTime=2015-03-04, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8eb4e59819, moduleTitle=阿斯利康宣布成立抗感染药物研发新公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8eb4e59819)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301418, encodeId=64aa1301418f1, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=武田药业与Mersana签订价值3亿美元肿瘤ADC药物研发协议, objectType=article, longId=45446, objectId=474f45446bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=474f45446bc, replyNumber=0, likeNumber=62, createdTime=2015-01-16, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=474f45446bc, moduleTitle=武田药业与Mersana签订价值3亿美元肿瘤ADC药物研发协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=474f45446bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301417, encodeId=729c130141e54, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Moderna再获4亿5千万风投剑指mRNA药物研发, objectType=article, longId=45125, objectId=fd874512592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd874512592, replyNumber=0, likeNumber=71, createdTime=2015-01-09, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd874512592, moduleTitle=Moderna再获4亿5千万风投剑指mRNA药物研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd874512592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301416, encodeId=877c130141632, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=抗癌药物研发：在失败中涅槃, objectType=article, longId=44577, objectId=d907445e7b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d907445e7b7, replyNumber=0, likeNumber=62, createdTime=2014-12-26, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d907445e7b7, moduleTitle=抗癌药物研发：在失败中涅槃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d907445e7b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301415, encodeId=628d1301415d3, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=不差钱！辉瑞再砸$3亿支持长效生长激素药物研发！, objectType=article, longId=44187, objectId=b67a4418e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b67a4418e93, replyNumber=0, likeNumber=69, createdTime=2014-12-19, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b67a4418e93, moduleTitle=不差钱！辉瑞再砸$3亿支持长效生长激素药物研发！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b67a4418e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301414, encodeId=b2b2130141451, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle="没事走两步" 美国拟要求将药物研发临床数据信息上网公布, objectType=article, longId=42950, objectId=1d7942950b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d7942950b6, replyNumber=0, likeNumber=63, createdTime=2014-11-22, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d7942950b6, moduleTitle="没事走两步" 美国拟要求将药物研发临床数据信息上网公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d7942950b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301413, encodeId=05a9130141318, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Revance新一代肉毒素美容药物研发进程推迟, objectType=article, longId=42655, objectId=d85242655e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85242655e3, replyNumber=0, likeNumber=72, createdTime=2014-11-19, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85242655e3, moduleTitle=Revance新一代肉毒素美容药物研发进程推迟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85242655e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301412, encodeId=46ff1301412b5, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=药物研发策略正在剧变，全球都在变！, objectType=article, longId=42618, objectId=c39e4261837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c39e4261837, replyNumber=0, likeNumber=80, createdTime=2014-11-16, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c39e4261837, moduleTitle=药物研发策略正在剧变，全球都在变！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c39e4261837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301411, encodeId=a02c1301411d7, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=阳性化合物：药物研发者的心头之“痛”, objectType=article, longId=41138, objectId=20c14113849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20c14113849, replyNumber=0, likeNumber=62, createdTime=2014-10-13, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20c14113849, moduleTitle=阳性化合物：药物研发者的心头之“痛”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20c14113849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301410, encodeId=3ede13014103c, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=罗宾威廉姆斯之死和抑郁症的药物研发, objectType=article, longId=39127, objectId=98733912ecc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98733912ecc, replyNumber=0, likeNumber=67, createdTime=2014-08-16, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98733912ecc, moduleTitle=罗宾威廉姆斯之死和抑郁症的药物研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98733912ecc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301409, encodeId=edec130140914, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Nature 子刊：靶点和先导物功能哪个对药物研发更重要？, objectType=article, longId=38115, objectId=9327381155c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9327381155c, replyNumber=0, likeNumber=65, createdTime=2014-07-24, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9327381155c, moduleTitle=Nature 子刊：靶点和先导物功能哪个对药物研发更重要？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9327381155c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301408, encodeId=217e130140834, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=罗氏拟17.25亿收购Seragon 增强乳腺癌药物研发实力, objectType=article, longId=37393, objectId=a0913e39307, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0913e39307, replyNumber=0, likeNumber=74, createdTime=2014-07-06, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0913e39307, moduleTitle=罗氏拟17.25亿收购Seragon 增强乳腺癌药物研发实力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0913e39307)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301407, encodeId=1439130140e46, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=未来药物研发的六大走向, objectType=article, longId=37086, objectId=f5493e086eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5493e086eb, replyNumber=0, likeNumber=79, createdTime=2014-06-28, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5493e086eb, moduleTitle=未来药物研发的六大走向, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5493e086eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301406, encodeId=93c113014067d, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=ASCO 2014：“界定”抗癌药物研发的“临床价值”, objectType=article, longId=35980, objectId=36243598020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36243598020, replyNumber=0, likeNumber=92, createdTime=2014-06-06, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36243598020, moduleTitle=ASCO 2014：“界定”抗癌药物研发的“临床价值”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36243598020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301405, encodeId=ae12130140515, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=2014年全球药物研发热门靶点, objectType=article, longId=31082, objectId=b43e3108274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b43e3108274, replyNumber=0, likeNumber=68, createdTime=2014-02-26, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b43e3108274, moduleTitle=2014年全球药物研发热门靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b43e3108274)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301404, encodeId=075213014042e, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Cell ：复旦教授破译TET2蛋白三维结构，有望用于白血病药物研发, objectType=article, longId=27716, objectId=211b2e71647, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=211b2e71647, replyNumber=0, likeNumber=60, createdTime=2013-12-11, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=211b2e71647, moduleTitle=Cell ：复旦教授破译TET2蛋白三维结构，有望用于白血病药物研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=211b2e71647)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301403, encodeId=bc13130140371, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=肺癌靶向药物研发紧迫, objectType=article, longId=27533, objectId=1bc52e533d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bc52e533d8, replyNumber=0, likeNumber=82, createdTime=2013-12-06, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bc52e533d8, moduleTitle=肺癌靶向药物研发紧迫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bc52e533d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301402, encodeId=19ab130140250, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=EFPIA和PhRMA同意适当公开其药物研发纪录, objectType=article, longId=22424, objectId=a6ab224249a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6ab224249a, replyNumber=0, likeNumber=60, createdTime=2013-08-02, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6ab224249a, moduleTitle=EFPIA和PhRMA同意适当公开其药物研发纪录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6ab224249a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药物研发

2020-05-29

huirong (审核中...)

前往app查看评论内容

#药物研发#

Science：药物研发新革命

2015-05-10

huirong (审核中...)

前往app查看评论内容

#药物研发#

Google如何用机器学习帮助药物研发？

2015-03-07

huirong (审核中...)

前往app查看评论内容

#药物研发#

阿斯利康宣布成立抗感染药物研发新公司

2015-03-04

huirong (审核中...)

前往app查看评论内容

#药物研发#

武田药业与Mersana签订价值3亿美元肿瘤ADC药物研发协议

2015-01-16

huirong (审核中...)

前往app查看评论内容

#药物研发#

Moderna再获4亿5千万风投剑指mRNA药物研发

2015-01-09

huirong (审核中...)

前往app查看评论内容

#药物研发#

抗癌药物研发：在失败中涅槃

2014-12-26

huirong (审核中...)

前往app查看评论内容

#药物研发#

不差钱！辉瑞再砸$3亿支持长效生长激素药物研发！

2014-12-19

huirong (审核中...)

前往app查看评论内容

#药物研发#

"没事走两步" 美国拟要求将药物研发临床数据信息上网公布

2014-11-22

huirong (审核中...)

前往app查看评论内容

#药物研发#

Revance新一代肉毒素美容药物研发进程推迟

2014-11-19

huirong (审核中...)

前往app查看评论内容

#药物研发#

药物研发策略正在剧变，全球都在变！

2014-11-16

huirong (审核中...)

前往app查看评论内容

#药物研发#

阳性化合物：药物研发者的心头之“痛”

2014-10-13

huirong (审核中...)

前往app查看评论内容

#药物研发#

罗宾威廉姆斯之死和抑郁症的药物研发

2014-08-16

huirong (审核中...)

前往app查看评论内容

#药物研发#

Nature 子刊：靶点和先导物功能哪个对药物研发更重要？

2014-07-24

huirong (审核中...)

前往app查看评论内容

#药物研发#

罗氏拟17.25亿收购Seragon 增强乳腺癌药物研发实力

2014-07-06

huirong (审核中...)

前往app查看评论内容

#药物研发#

未来药物研发的六大走向

2014-06-28

huirong (审核中...)

前往app查看评论内容

#药物研发#

ASCO 2014：“界定”抗癌药物研发的“临床价值”

2014-06-06

huirong (审核中...)

前往app查看评论内容

#药物研发#

2014年全球药物研发热门靶点

2014-02-26

huirong (审核中...)

前往app查看评论内容

#药物研发#

Cell ：复旦教授破译TET2蛋白三维结构，有望用于白血病药物研发

2013-12-11

huirong (审核中...)

前往app查看评论内容

#药物研发#

肺癌靶向药物研发紧迫

2013-12-06

huirong (审核中...)

前往app查看评论内容

#药物研发#

EFPIA和PhRMA同意适当公开其药物研发纪录

2013-08-02

科室
- - 订阅+
  - 更多科室
工具
服务